SEC Comment Letter for Ampio Pharmaceuticals, Inc. (AMPE) (CIK 0001411906) — Jan 16, 2020
Ampio Pharmaceuticals, Inc. (AMPE) (CIK 0001411906)
Date: Jan. 16, 2020 · CIK: 0001411906 · Accession: 0000000000-20-000410
AI Filing Summary & Sentiment
File numbers found in text: 001-35182
Letter
January 16, 2020 Daniel G. Stokely Chief Financial Officer, Treasurer and Secretary Ampio Pharmaceuticals, Inc. 373 Inverness Parkway, Suite 200 Englewood, Colorado 80112 Re:Ampio Pharmaceuticals, Inc. Form 10-K for the Fiscal Year Ended December 31, 2018 Filed March 18, 2019 File No. 001-35182 Dear Mr. Stokely: We have completed our review of your filings. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences
Show Raw Text
January 16, 2020
Daniel G. Stokely
Chief Financial Officer, Treasurer and Secretary
Ampio Pharmaceuticals, Inc.
373 Inverness Parkway, Suite 200
Englewood, Colorado 80112
Re:Ampio Pharmaceuticals, Inc.
Form 10-K for the Fiscal Year Ended December 31, 2018
Filed March 18, 2019
File No. 001-35182
Dear Mr. Stokely:
We have completed our review of your filings. We remind you that the company and its
management are responsible for the accuracy and adequacy of their disclosures, notwithstanding
any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation Finance
Office of Life Sciences